Orphan Drugs Market To Reach USD 269210 Million By 2029, Witnessing A CAGR of 9.9% | Valuates Reports

News provided by

Jun 14, 2023, 11:30 ET

BANGALORE, India, June 14, 2023 /PRNewswire/ -- Orphan Drug Mark et segmented by Type - Oncology, Gastrointestinal, Pulmonary, Neurology, Hematology, Cardio-vascular, Metabolic Disorders, Endocrinology, Infectious Diseases, Others, by Application - Baby and Child, Teenager, Adult, Other. Global Opportunity Analysis and Industry Forecast 2023-2029. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.

The global Orphan Drugs market was valued at USD 153130 million in 2022 and is anticipated to reach USD 269210 million by 2029, witnessing a CAGR of 9.9% during the forecast period 2023-2029.

Major factors driving the growth of the Orphan Drugs Market

The Orphan Drugs Market is expanding because of favorable government regulations and an increase in the occurrence of uncommon illnesses.

Increasing R&D activities will support global orphan drugs market development. During the projection period, there are likely to be lucrative prospects for market expansion due to the high growth potential in untapped emerging economies and the increase in new indications for well-known orphan medications.

Browse The Table of Contents And List of Figures At https://reports.valuates.com/reports/QYRE-Auto-29S2943/global-orphan-drugs

TRENDS INFLUENCING THE GROWTH OF ORPHAN DRUGS MARKET

Pharmaceuticals used to detect and treat unusual medical conditions are known as orphan drugs. These drugs often have a tiny market since they are made for a small patient group and are created to meet a particular public health need. Numerous oncological, metabolic, hematologic, chronic, progressive, viral, and neurological conditions can be successfully treated with them. Lymphoma, glioma, leukemia, cystic fibrosis, ovarian cancer, immunologic, multiple myeloma, and renal cell carcinoma are all life-threatening, degenerative, and debilitating illnesses that call for certain treatment choices that are efficient for their particular symptoms. This factor is expected to drive the growth of the Orphan Drugs Market

Governments all across the globe have put in place a variety of incentives and rules to promote the creation of orphan medications. These include increased market exclusivity, tax breaks, subsidies for research, and accelerated regulatory procedures. Pharmaceutical firms have been enticed to engage in the development of orphan drugs thanks to these incentives. This factor is expected to drive the growth of the Orphan Drugs Market

The knowledge of uncommon illnesses has improved as a result of developments in genetic research and diagnostic methods. This increased the possibility of successful medication development by enabling the identification of particular molecular targets and pathways that can be addressed by orphan pharmaceuticals. This factor is expected to drive the growth of the Orphan Drugs Market

Patient advocacy organizations are essential in promoting financing for research, educating the public about rare illnesses, and encouraging the creation of orphan medications. Their initiatives have increased public and governmental support for the development of orphan drugs and brought attention to these diseases. This factor is expected to drive the growth of the Orphan Drugs Market

Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-29S2943/Global_Orphan_Drugs_Market

ORPHAN DRUGS MARKET SHARE ANALYSIS

With a market share of roughly 10%, Bristol-Myers Squibb is among the top orphan medication manufacturers in the world. Other leading manufacturers include Roche and Novartis.

The largest market is North America, which accounts for over 40% of sales, followed by Asia-Pacific. The enormous investment in orphan pharmaceuticals, the large patient population, and the existence of important market participants have all contributed to North America's high market share and the creation of complex and cutting-edge goods.

With a share of more than 60%, oncology is the largest sector by type.

The adult market has a stake of roughly 40% in terms of applicability.

Inquire For Customization :

https://reports.valuates.com/request/customisation/QYRE-Auto-29S2943/Global_Orphan_Drugs_Market

Market By Region

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-29S2943/Global_Orphan_Drugs_Market

Key players

Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly

Inquire For Chapter Cost : https://reports.valuates.com/request/chaptercost/QYRE-Auto-29S2943/Global_Orphan_Drugs_Market

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-29S2943&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

- Global Urethritis Drugs Market

- Global Gastrointestinal Drugs Market was valued at USD 34710 million in 2022 and is anticipated to reach USD 43470 million by 2029, witnessing a CAGR of 3.2% during the forecast period 2023-2029.

- Global Essential Thrombocythemia Drug Market

- Global Orphan Indication Treatment Market

- Global Small Molecule Nucleic Acid Drug Market

- Global Oral Mucositis Treatment Drug Market

- Amino Acid Metabolism Disorder Drug Market

- Transthyretin Amyloidosis Drug Market

- Conjunctivitis Drugs estimated at US$ 885.9 million in the year 2022, is projected to reach a revised size of US$ 983.6 million by 2028, growing at a CAGR of 1.8% during the forecast period 2022-2028.

- Viral Conjunctivitis Drugs Market

- Disposable Medical Tubing Sales Market

- Medical Corrugated Tubing Sales Market

- Medical Grade Silicone Tubing Sales Market was valued at USD 550.6 million in 2020 and is expected to reach USD 982.7 million by the end of 2027, growing at a CAGR of 8.8% during 2021-2027.

- Polyimide Medical Tubing Market Outlook 2022

- Polyimide Tubing Market was valued at USD 353 million in 2022 and is anticipated to reach USD 453.5 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029.

- Extruded Medical Tubing Market

- Disposable Medical Tubing Market

- Medical Multi Lumen Tube Market

- Medical Heat Shrinkable Tube Market

- Medical Polyimide Tubing Market

- Moisture Proof Heat Shrink Tube Market

- Heat Shrink Tubing Kits Market

- Synthetic Biology market size is estimated to be worth USD 10060 million in 2022 and is forecast to be a readjusted size of USD 33120 million by 2028 with a CAGR of 22.0% during the review period.

- Genome Editing Market is projected to reach a revised size of USD 6739.8 million by 2028, growing at a CAGR of 9.3% during the forecast period 2022-2028.

- Microfluidics Market is projected to reach USD 7397 million by 2028 from an estimated USD 3496.8 million in 2022, at a CAGR of 13.3% during 2023 and 2028.

- Site Directed Mutagenesis System Market

- 3D Cell Culture Market

- Genome Editing Market is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.

- Cell Analysis Market is projected to reach USD 25610 Million by 2027, from USD 19740 Million in 2020, at a Compound Annual Growth Rate (CAGR) of 3.7% during 2021-2027.

- Cell Culture Market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

- DNA Sequencing Market size was USD 13380 million and it is expected to reach USD 48700 million by the end of 2027, with a CAGR of 20.4% during 2021-2027

- Bioreactors Market is estimated to be worth USD 1523.1 million in 2022 and is forecast to a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.

- Single use Bioprocessing Market is projected to reach USD 6956.3 million by 2027, from USD 3905.3 million in 2020, at a CAGR of 10.1% during 2021-2027.

- Digital PCR Market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.

- Global Clinical Flow Cytometry Market Research Report 2022

- Flow Cytometry Market estimated at USD 5.1 billion in the year 2022, is projected to reach a revised size of USD 8.4 billion by 2028, growing at a CAGR of 8.7% during the forecast period 2022-2028.

- Antimicrobial susceptibility testing market was valued at USD 3040.00 million in 2020 and is projected to reach USD 4736.03 million by 2030 registering a CAGR of 5.8% from 2021 to 2030.

- Neurostimulation Devices market is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.

- Digital PCR (DPCR) and QPCR market is estimated to be worth USD 1419.2 million in 2022 and is forecast to a readjusted size of USD 2165.8 million by 2028 with a CAGR of 7.3% during the review period.

- Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.

- Biometrics market is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.

- Fiducial Markers market is estimated to be worth USD 104.8 million in 2022 and is forecast to be a readjusted size of USD 131.4 million by 2028 with a CAGR of 3.9% during the review period

- Dialysis Market was valued at USD 91,205.0 million in 2020 and is estimated to reach USD 129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028.

- The global Urology Devices market was valued at USD 29300 million in 2022 and is anticipated to reach USD 39810 million by 2029, witnessing a CAGR of 4.0% during the forecast period 2023-2029.

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:

Valuates Reports
[email protected]
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports
https://reports.valuates.com/sitemap/html/reports/651
https://reports.valuates.com/sitemap/html/reports/652
https://reports.valuates.com/sitemap/html/reports/653